Your free trial is not converting to paid. Where it breaks.
A trial has three stages, not one, and the rate you watch can climb while your customer count falls. The 2026 benchmark, and two experiments that disagree about trial length.
Your trial signups look fine and almost none of them pay. The reflex is to check your rate against a published benchmark, but the largest 2026 dataset shows that benchmark describes almost nobody, and that the rate can climb while your customer count falls.
Which stage of your trial is losing people?
A trial has three stages, not one: visitors who sign up, signups who reach the point where the product works, and those users who pay. Each has its own rate and its own cause. Most founders quote a single number for all three, which is why the fix rarely lands where the loss is.
Pull all three before changing anything.
- Visitors to signup. Sessions divided into trial starts. Under 2% and the problem is the page, not the product.
- Signup to first real use. The share completing the one action your product exists to do. Import, connect, publish, send. Not a welcome tour.
- First real use to paid. Of those who got it working, how many bought. Only this one is about price.
Whichever is worst is where the money goes.
Not sure the first number is your problem? Revslip checks the pages in front of your signup.
Why is your free trial not converting to paid?
Often because you are reading a ratio you control the bottom of. Anything that makes signing up harder strips the least committed people out of the denominator, so the percentage rises. Fewer people in, better number on the dashboard, no more customers than last month.
The 2026 Conversion Report, from Kyle Poyar with ChartMogul and ProductLed, traced 1,000 visitors through four entry models. Read rates and customer counts together.
- 5 customers from 90 freemium signups, a 5.5% free-to-paid rate
- 3.6 customers from 45 free trial signups, an 8% free-to-paid rate
- 10.5 customers from 35 credit-card trial signups, a 30% rate
The middle row beats the top row on rate and produces 28% fewer customers.
Shrink the denominator and the number improves while the business does not.
What does the 2026 conversion data actually show?
That there is no normal. Across 200 software products surveyed in January 2026, the median free-to-paid rate was 8%, but one in five trial products converted under 2.5% and nearly one in four converted above 25%. The spread between the top fifth and the bottom fifth is roughly tenfold.
Which makes "is 8% good" a useless question. The distribution has two humps and the median sits in the dip. These are also self-reported estimates, not measured events, so take the shape as the finding, not the figure.
Does a longer free trial convert better?
It moved the business result and left the headline rate alone. A randomized field experiment on 680,588 new users, published in Frontiers in Psychology in 2025, extended a trial from three days to seven. Trial adoption rose 11.1%. Conversion from trial to paid, measured at the end of the trial, did not move at all.
Adoption went from 0.856% to 0.951%. The effect on immediate conversion was a coefficient of 0.00016 at p above 0.1, which is nothing. Delayed conversion did rise, and so did overall subscriptions across the following two years. The extra days bought customers, just not on the day the dashboard watched.
A second experiment pushes the other way. In Management Science in 2023, Yoganarasimhan, Barzegary and Pani found shorter trials maximised acquisition, retention and profitability, seven days beating fourteen and thirty. Idle days late in a trial are not thinking time.
They agree on a number without agreeing on a direction. One moved up to seven days and won, the other moved down to seven and won. Neither supports the assumption under most trial-length arguments, that the dial moves paying customers smoothly.
Where this cuts against us ChartMogul sells subscription analytics and we sell audits, so both of us profit from you staring harder at these numbers. The two results holding up the harder half of this post come from journals that sell nothing.
What to change before you touch the trial length
Work on the stage with the worst number, and if that is the middle one, shorten the time to first real use. Trial length, reminder emails and last-day discounts all act on people who already decided. The middle stage is where people who wanted your product never reached it.
- Name the one action. The single thing a user must do for the product to be worth paying for. If your team disagrees, that is the finding.
- Count the clicks to it. Sign up in a clean browser. Anything between the confirmation email and that action can probably go.
- Do the setup for them. Sample data, a prefilled project, a template. An empty screen on day one is where people decide not to return.
- Say what the trial is for. "See your first report in four minutes" beats "start free trial".
To see what your signup page does to that first number, run a free audit.
What should move, and by when
Track the three rates separately for one full trial cycle plus a fortnight, because nobody converts on the day you ship the change. If time to first real use drops and the middle rate rises, it worked. If only the last rate rises, check your signups did not fall to produce it.
Then price it, with one published formula you can check by hand:
traffic × conversion gap × average order value × mobile weight
Say 9,000 visitors a month, 4.2% starting a trial, so 378 trials. At 6% paying that is 22 customers, at 9% it is 34. Twelve more at €89 each is €1,068 in new monthly recurring revenue.
When you should leave the rate alone
When your trial volume is too small to read. Moving 80 trials from 6% to 9% is seven customers against five, an ordinary fortnight either way. Fix the visitor-to-signup stage first, because that stage has a denominator big enough to measure a change against.
There is also a boundary on what we can tell you. Revslip crawls what is public: the pricing page, the signup form, the copy in front of the trial. The trial itself sits behind a login, so our crawl stops at the door where a middle-stage problem lives. We can flag a form field nobody can answer. We cannot watch someone abandon your import screen.
The 134 businesses Revslip has audited skew too. Their owners already suspected something was wrong, making that sample a waiting room, not a population.
What founders ask when the trial stalls
Three come up every time, and none is about trial length. Founders want to know whether to demand a card, whether their rate is bad or their category simply is, and how to price the gap before committing budget to it. The answers are shorter than expected.
Should I ask for a credit card up front?
In the 2026 report they converted at 30% against 8% for trials overall, and produced 10.5 customers per 1,000 visitors against 3.6, winning on both counts. Whether it wins for you depends on whether people hand a card to a product like yours unseen.
Is my conversion rate bad, or is my category like this?
It depends which of the three you mean, which is the argument for splitting them. The ecommerce version sits in is my conversion rate bad, including why sector averages hide more than they show.
How do I put a euro figure on this before spending anything?
How to calculate conversion loss works through every input, including the one that is a guess rather than a measurement.
If visitor-to-signup is your worst stage, the traffic but no sales diagnostic runs that split, and the conversion leak index ranks what breaks.